Patent 10975023 was granted and assigned to Signum Biosciences on April, 2021 by the United States Patent and Trademark Office.
The present invention provides compounds useful in treating or preventing inflammation acne, bacterial conditions and promoting the appearance of healthy skin and compositions including these compounds.